Search

WEDNESDAY, Dec. 2, 2020 (HealthDay News) — Among noncritical hospitalized COVID-19 patients, admission hyperglycemia is an independent predictor of all-cause mortality, according to a study published online Nov. 4 in the Annals of Medicine. Francisco Javier Carrasco-Sánchez, M.D., Ph.D., from Jiménez University Hospital in Huelva, Spain, and colleagues conducted a retrospective multicenter study involving 11,312...

The implementation of treatment regimens for Hodgkin lymphoma (HL) in the face of COVID-19 is often individualized. Treatments for HL can result in an increased risk of infections and complications due to the immunosuppressive effects of therapy. In addition, standard treatments for HL, including bleomycin and radiation therapy, can increase the risk of pulmonary toxicity....

MONDAY, Oct. 26, 2020 (HealthDay News) — The COVID-19 pandemic may have negatively impacted osteoporosis management, according to a study published online Oct. 14 in Osteoporosis International. Eugene V. McCloskey, M.D., from the University of Sheffield in the United Kingdom, and colleagues quantified the global impact of the COVID-19 pandemic on management of osteoporosis by...

A retrospective study led by Dr. Victoria Silver at Louisiana State University, Health Sciences Center in New Orleans analyzed how race and asthma influence COVID-19 outcomes. The study began around the time that Louisiana was deemed to have the fastest-growing COVID-19 outbreak worldwide. Dr. Silver’s work recognizes the disproportionate number of COVID-19-related deaths of Black...

One of the studies that will be presented at the 2021 ASH Annual Meeting & Exposition is a retrospective study, published in Blood, on the efficacy of the COVID-19 vaccines in adult patients with lymphomas undergoing immunochemotherapy. Data were gathered from adult patients with lymphomas identified to have received the COVID-19 vaccine, either two doses...

People with MS deal with various types of burdensome effects of their disease. This study analyzed these effects in the context of the COVID-19 pandemic. The COVID-19 pandemic had wide-ranging impacts on mental health symptoms and quality of life. This change was apparent in both the general population and those with varying mental and physical...

THURSDAY, Oct. 22, 2020 (HealthDay News) — The U.S. Food and Drug Administration has approved the first treatment for COVID-19. Remdesivir, sold under the brand name Veklury, is approved for use in adults and children 12 years and older hospitalized with COVID-19. The drug is indicated for use only in a hospital or health care...

FRIDAY, Oct. 23, 2020 (HealthDay News) — Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit (ICU), although other findings are conflicting, according to three studies and an editorial published online Oct. 20 in JAMA Internal Medicine. Shruti Gupta, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues...

TUESDAY, Nov. 24, 2020 (HealthDay News) — More than one-fifth of patients with COVID-19 presenting with neurologic findings who underwent neuroimaging had critical findings, according to a study scheduled for presentation at the annual meeting of the Radiological Society of North America, held virtually from Nov. 29 to Dec. 5. Colbey W. Freeman, M.D., from...

In this MD Newsline exclusive interview with pulmonary and critical care physician Dr. Jamie Rutland, we discuss asthma management challenges and disparities in the wake of COVID-19. MD Newsline: What are the biggest challenges that pulmonologists and other physicians treating asthma are tasked with in the wake of COVID-19? Dr. Jamie Rutland: “The biggest issue...